Literature DB >> 24472828

Characterization of inflammatory responses during intranasal colonization with Streptococcus pneumoniae.

Alicja Puchta1, Chris P Verschoor, Tanja Thurn, Dawn M E Bowdish.   

Abstract

Nasopharyngeal colonization by Streptococcus pneumoniae is a prerequisite to invasion to the lungs or bloodstream(1). This organism is capable of colonizing the mucosal surface of the nasopharynx, where it can reside, multiply and eventually overcome host defences to invade to other tissues of the host. Establishment of an infection in the normally lower respiratory tract results in pneumonia. Alternatively, the bacteria can disseminate into the bloodstream causing bacteraemia, which is associated with high mortality rates(2), or else lead directly to the development of pneumococcal meningitis. Understanding the kinetics of, and immune responses to, nasopharyngeal colonization is an important aspect of S. pneumoniae infection models. Our mouse model of intranasal colonization is adapted from human models(3) and has been used by multiple research groups in the study of host-pathogen responses in the nasopharynx(4-7). In the first part of the model, we use a clinical isolate of S. pneumoniae to establish a self-limiting bacterial colonization that is similar to carriage events in human adults. The procedure detailed herein involves preparation of a bacterial inoculum, followed by the establishment of a colonization event through delivery of the inoculum via an intranasal route of administration. Resident macrophages are the predominant cell type in the nasopharynx during the steady state. Typically, there are few lymphocytes present in uninfected mice(8), however mucosal colonization will lead to low- to high-grade inflammation (depending on the virulence of the bacterial species and strain) that will result in an immune response and the subsequent recruitment of host immune cells. These cells can be isolated by a lavage of the tracheal contents through the nares, and correlated to the density of colonization bacteria to better understand the kinetics of the infection.

Entities:  

Mesh:

Year:  2014        PMID: 24472828      PMCID: PMC4089492          DOI: 10.3791/50490

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  35 in total

1.  Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae.

Authors:  J O Kim; J N Weiser
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

2.  Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

Authors:  W P Hausdorff; J Bryant; P R Paradiso; G R Siber
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

3.  Nasal colonization with Streptococcus pneumoniae includes subpopulations of surface and invasive pneumococci.

Authors:  David E Briles; Lea Novak; Muneki Hotomi; Frederik W van Ginkel; Janice King
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance.

Authors:  Aaron L Nelson; Aoife M Roche; Jane M Gould; Kannie Chim; Adam J Ratner; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2006-11-06       Impact factor: 3.441

5.  Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization.

Authors:  Tera L McCool; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

6.  Identification of splenic reservoir monocytes and their deployment to inflammatory sites.

Authors:  Filip K Swirski; Matthias Nahrendorf; Martin Etzrodt; Moritz Wildgruber; Virna Cortez-Retamozo; Peter Panizzi; Jose-Luiz Figueiredo; Rainer H Kohler; Aleksey Chudnovskiy; Peter Waterman; Elena Aikawa; Thorsten R Mempel; Peter Libby; Ralph Weissleder; Mikael J Pittet
Journal:  Science       Date:  2009-07-31       Impact factor: 47.728

7.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.

Authors:  Richard Malley; Philipp Henneke; Sarah C Morse; Michael J Cieslewicz; Marc Lipsitch; Claudette M Thompson; Evelyn Kurt-Jones; James C Paton; Michael R Wessels; Douglas T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-04       Impact factor: 11.205

8.  Organ-specific models of Streptococcus pneumoniae disease.

Authors:  Carlos J Orihuela; Geli Gao; Mackenzie McGee; Jun Yu; Kevin P Francis; Elaine Tuomanen
Journal:  Scand J Infect Dis       Date:  2003

9.  Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation.

Authors:  Jonathan M Cohen; Suneeta Khandavilli; Emilie Camberlein; Catherine Hyams; Helen E Baxendale; Jeremy S Brown
Journal:  PLoS One       Date:  2011-10-07       Impact factor: 3.240

10.  Pneumococcal capsular polysaccharide structure predicts serotype prevalence.

Authors:  Daniel M Weinberger; Krzysztof Trzciński; Ying-Jie Lu; Debby Bogaert; Aaron Brandes; James Galagan; Porter W Anderson; Richard Malley; Marc Lipsitch
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

View more
  13 in total

1.  Protection against Streptococcus pneumoniae Invasive Pathogenesis by a Protein-Based Vaccine Is Achieved by Suppression of Nasopharyngeal Bacterial Density during Influenza A Virus Coinfection.

Authors:  M Nadeem Khan; Qingfu Xu; Michael E Pichichero
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

2.  Streptococcus pneumoniae Colonization Disrupts the Microbial Community within the Upper Respiratory Tract of Aging Mice.

Authors:  Netusha Thevaranjan; Fiona J Whelan; Alicja Puchta; Eta Ashu; Laura Rossi; Michael G Surette; Dawn M E Bowdish
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

3.  Prophylactic Inhibition of Colonization by Streptococcus pneumoniae with the Secondary Bile Acid Metabolite Deoxycholic Acid.

Authors:  Jorge E Vidal; Meagan N Wier; Uriel A Angulo-Zamudio; Erin McDevitt; Ana G Jop Vidal; Babek Alibayov; Anna Scasny; Sandy M Wong; Brian J Akerley; Larry S McDaniel
Journal:  Infect Immun       Date:  2021-09-20       Impact factor: 3.441

4.  Alternaria alternata challenge at the nasal mucosa results in eosinophilic inflammation and increased susceptibility to influenza virus infection.

Authors:  M Ma; J L Redes; C M Percopo; K M Druey; H F Rosenberg
Journal:  Clin Exp Allergy       Date:  2018-04-15       Impact factor: 5.018

5.  Effectiveness of Polyvalent Bacterial Lysate and Autovaccines Against Upper Respiratory Tract Bacterial Colonization by Potential Pathogens: A Randomized Study.

Authors:  Olaf Zagólski; Paweł Stręk; Andrzej Kasprowicz; Anna Białecka
Journal:  Med Sci Monit       Date:  2015-10-05

6.  Nasal Tissue Extraction Is Essential for Characterization of the Murine Upper Respiratory Tract Microbiota.

Authors:  L Patrick Schenck; Joshua J C McGrath; Daphnée Lamarche; Martin R Stämpfli; Dawn M E Bowdish; Michael G Surette
Journal:  mSphere       Date:  2020-12-16       Impact factor: 4.389

7.  Enzymatic Hydrolysis of Pneumococcal Capsular Polysaccharide Renders the Bacterium Vulnerable to Host Defense.

Authors:  Dustin R Middleton; Amy V Paschall; Jeremy A Duke; Fikri Y Avci
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

8.  TNF Drives Monocyte Dysfunction with Age and Results in Impaired Anti-pneumococcal Immunity.

Authors:  Alicja Puchta; Avee Naidoo; Chris P Verschoor; Dessi Loukov; Netusha Thevaranjan; Talveer S Mandur; Phuong-Son Nguyen; Manel Jordana; Mark Loeb; Zhou Xing; Lester Kobzik; Maggie J Larché; Dawn M E Bowdish
Journal:  PLoS Pathog       Date:  2016-01-14       Impact factor: 6.823

Review 9.  Role of Inflammatory Risk Factors in the Pathogenesis of Streptococcus pneumoniae.

Authors:  Ifrah Sohail; Sumit Ghosh; Santhosh Mukundan; Susan Zelewski; M Nadeem Khan
Journal:  Front Immunol       Date:  2018-10-02       Impact factor: 7.561

10.  Airway Microbiota-Host Interactions Regulate Secretory Leukocyte Protease Inhibitor Levels and Influence Allergic Airway Inflammation.

Authors:  Natalia Jaeger; Ryan T McDonough; Anne L Rosen; Ariel Hernandez-Leyva; Naomi G Wilson; Michael A Lint; Emilie V Russler-Germain; Jiani N Chai; Leonard B Bacharier; Chyi-Song Hsieh; Andrew L Kau
Journal:  Cell Rep       Date:  2020-11-03       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.